Tech Company Financing Transactions
Mitralign Funding Round
Mitralign secured a $39.8 million Series E venture capital round on 5/17/2016. Backers included private investors.
Transaction Overview
Company Name
Announced On
5/17/2016
Transaction Type
Venture Equity
Amount
$39,800,000
Round
Series E
Investors
Proceeds Purpose
The Company plans to continue growing its platform by pursuing US and CE regulatory approval for the commercialization of their Trialign system in parallel with preparations for commercial launch in Europe of their Mitralign Percutaneous Annuloplasty System (MPAS).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3 Highwood Dr. 200E
Tewksbury, MA 01876
USA
Tewksbury, MA 01876
USA
Phone
Website
Email Address
Overview
We are currently developing an innovative, catheter- based mitral valve repair system that not only provides an alternative to open heart surgery but emulates the traditional surgical repair technique. The condition treated,mitral valve regurgitation (MR), is common in patients with Congestive Heart Failure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Geoffrion
Chief Operating Officer
Lisa Heine
Vice President
Adam Groothuis
VP - Finance
Lisa Mastromattei
VP - Marketing
David Schleifer
VP - Operations
Scott Oppenheim
VP - R & D
Christopher Lee
Browse more venture capital transactions:
Prev: 5/17/2016: Axion BioSystems venture capital transaction
Next: 5/17/2016: Ellie Kai venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs